Komatsu et al.
H-2′), 2.33 (1H, dt, J ) 12.4 and 3.3 Hz, H-2′), 3.47 (3H, s,
OMe), 4.32 (1H, q, J ) 6.6 Hz, H-5′), 5.06 (1H, d, J ) 3.3 Hz,
H-1′), 5.58 (1H, br, H-4′), 5.63 (1H, ddd, J ) 3.1, 5.1, and 12.4
Hz, H-3′), 7.37 (2H, d, J ) 7.9 Hz, Ph), 7.57 (3H, t, J ) 7.6 Hz,
Ph), 7.70 (1H, tt, J ) 7.5 and 1.3 Hz, Ph), 7.83 (2H, d, J ) 8.2
and 1.2 Hz, Ph), and 8.11 (2H, dd, J ) 8.2 and 1.2 Hz, Ph);
ESIMS m/z 393 (M + Na)+; HRESIMS m/z 393.1308 (M +
Na)+, calcd for C21H22O6Na 393.1314.
those of cyclosporin A (IC50 0.016 µg/mL) and ascomycin
(IC50 0.040 µg/mL), 2 showed no toxicity in a dose of 500
mg/kg in mice. Therefore, 2 may be a favorable immuno-
suppressive reagent. On the other hand, 1 showed no
suppressive activity on mouse MLR at 20 µg/mL. These
results suggested that 23-O-malonyl and 3′-O-pentanoyl
groups were important for the immunosuppressive activ-
ity of 2. Furthermore, 1 showed cytotoxicity against
murine lymphoma P388 cells (IC50 8.3 µg/mL), while 2
was not cytotoxic at 100 µg/mL.
Oxid a tive Degr a d a tion of th e Aglycon 3 of 1. The
aglycon 3 (9.6 mg) of 1 was treated with NaBH4 (1.2 mg) in
MeOH (500 µL) at room temperature for 40 min. After addition
of 5% aqueous AcOH (200 µL) and then evaporation of the
organic solvent, the residual aqueous solution was subjected
to an HP-20 column (H2O and then MeOH). The fraction eluted
with MeOH was evaporated in vacuo to give a residue (9.9
mg). To a solution of the residue in MeOH (300 µL) was added
a 28% solution of NaOMe in MeOH (18.5 µL), and the mixture
was stirred at room temperature for 6 h. After addition of
saturated aqueous NH4Cl, evaporation of the organic solvent,
and chromatography on an HP-20 column (H2O and then
MeOH), the MeOH-eluted portion (9.3 mg) was treated with
NaIO4 (4.9 mg) in MeOH/H2O (1:1; 600 µL) at room temper-
ature for 30 min. To this reaction mixture was added NaBH4
(2.2 mg), and stirring was continued at room temperature for
30 min. After evaporation of the organic solvent, and chroma-
tography on an HP-20 column (H2O and then MeOH), the
MeOH-eluted fraction (7.7 mg) was treated with pivaloyl
chloride (16 mg) and pyridine (400 µL) at room temperature
for 30 min. The reaction mixture was partitioned between
EtOAc and saturated aqueous NaHCO3, and the organic phase
was washed with saturated aqueous NH4Cl, H2O, and then
brine and evaporated in vacuo. The residue was subjected to
C18 HPLC [Develosil ODS-UG-5, Nomura Chemical Co., Ltd.,
10 × 250 mm; eluent CH3CN/H2O, 45:55 (∼5 min) to 50:50
(∼15 min); flow rate 2.5 mL/min; UV detection at 210 nm] to
afford the 15-pivaloyl ester of the C-1-C-15 segment (7; 0.4
mg, tR 11 min), the 17,27-bis-pivaloyl ester of the C-17-C-27
segment (8; 1.3 mg, tR 24 min), and the 28-pivaloyl ester of
the C-28-C-37 segment (9; 1.6 mg, tR 15 min).
Exp er im en ta l Section
Cu ltiva tion . The voucher specimen of N. brasiliensis
(strain IFM 0406) was deposited at the Center for Pathogenic
Fungi and Microbial Toxicoses, Chiba University (deposition
no. FERM BP-5498).5 This actinomycete was grown in broth
[glycerol (2.0%), polypepton (1.0%), and meat extract (0.5%)
in H2O, pH 7.0]. Cultures were incubated in a 150 L jar
fermentor at 32 °C for 4 days with stirring at 250 rpm and a
150 L/min aeration rate and were centrifuged.
Extr a ction a n d Sep a r a tion . The supernatant of the
fermentation broth (80 L) was passed through a Diaion HP-
20 column, washed with 2 M NaCl(aq) (20 L) and H2O (20 L),
and then eluted batchwise with MeOH/H2O (1:1, 20 L) and
MeOH (20 L). The fraction eluted with MeOH was chromato-
graphed on a silica gel column eluted with a stepwise gradient
of CHCl3/MeOH to yield a fraction (13.7 g) which was sepa-
rated by a C18 column with a stepwise gradient of MeOH/H2O.
The fraction eluted with 50-70% MeOH/H2O was further
separated by C18 HPLC (YMC-Pack ODS R&D, YMC Co., Ltd.,
2 × 25 cm; MeOH/H2O, 70:30; flow rate 10 mL/min; UV
detection at 205 nm) and then C18 HPLC again [YMC-Pack
ODS R&D; MeOH/H2O, 65:35 f 67:33, containing CF3CO2H
(25 ppm); flow rate 10 mL/min; UV detection at 205 nm] to
afford 1 (285 mg) and 2 (50 mg). Data for 1: colorless solid;
[R]D22 -21° (c 1.0, MeOH); IR (KBr) νmax 3402, 1703, and 1651
cm-1; UV (MeOH) λmax 210 nm (ꢀ 15400); 1H and 13C NMR
(Table 1); FABMS m/z 1019 (M + Na)+; HRFABMS m/z
1019.5760 (M + Na)+, calcd for C49H88O20Na 1019.5767.
Hyd r olysis of 1. 1 (50 mg) was dissolved in H2O (500 µL)
and heated at 110 °C for 9 h. The mixture was purified by C18
HPLC to afford an aglycon (3; 9.6 mg) and 4 (1.0 mg). Data
5,7-Isop r op yr id en e Aceta l of 7 (10). To a solution of the
15-pivaloyl ester of the C-1-C-15 segment (7, 0.4 mg) in MeOH
(10 µL) were added 2,2-dimethoxypropane (40 µL) and TsOH‚
H2O (0.02 mg), and the mixture was stirred at room temper-
ature for 40 min. After addition of saturated aqueous NaHCO3,
the mixture was extracted with EtOAc, and the organic layer
was washed with H2O and brine and evaporated in vacuo. The
residue was separated by preparative TLC (hexane/EtOAc, 1:1;
for 3: colorless solid; [R]D +22° (c 1.0, MeOH); H and 13C
NMR (Table 1); FABMS m/z 867 (M + H)+ and 889 (M + Na)+;
HRFABMS m/z 867.5356 (M + H)+, calcd for C43H79O17
867.5374.
21
1
1
four times) to afford compound 10 (0.4 mg): colorless oil; H
NMR (C6D6) δ 0.90 (3H, d, J ) 6.8 Hz, H3-38), 0.92 (1H, m,
H-6â), 1.14 (1H, m, H-6R), 1.18 (1H, m, H-11), 1.18 (1H, m,
H-10), 1.20 (9H, s, Piv), 1.25 (3H, s, â-CH3 of acetonide), 1.38
(1H, m, H-12), 1.42 (3H, s, R-CH3 of acetonide), 1.43 (1H, m,
H-8), 1.44 (1H, m, H-11), 1.52 (1H, m, H-8), 1.60 (2H, m, H2-
14), 1.70 (1H, m, H-10), 1.99 (1H, J ) 7.0 and 14.3 Hz, H-4â),
2.21 (1H, dd, J ) 7.4 and 14.3 Hz, H-4R), 3.45 (3H, s,1-OCH3),
3.51 (1H, m, H-13), 3.58 (1H, m, H-5), 4.88 (1H, m, H-9), 3.94
(1H, m, H-7), 4.15 (1H, dt, J ) 10.9 and 5.6 Hz, H-15), 4.32
(1H, dt, J ) 10.9 and 7.3 Hz, H-15), 5.96 (1H, d, J ) 15.4 Hz,
H-2), and 7.12 (1H, dt, J ) 15.4 and 7.6 Hz, H-3); ESIMS m/z
495 (M + Na)+; HRESIMS m/z 495.2927 (M + Na)+, calcd for
A solution of 4 (1.0 mg) in MeOH (200 µL) was treated with
6 M HCl(aq) (5 µL) at 100 °C for 30 min. After dilution with
H2O and then evaporation of organic solvent, the residue was
subjected to an HP-20 column (H2O and then MeOH). The
fraction eluted with MeOH was purified on a silica gel column
(acetone/hexane) to afford 5 (0.5 mg): [R]D -140° (c 0.1, H2O);
1H NMR (CDCl3) δ 1.28 (3H, d, J ) 6.7 Hz, H3-6′), 1.77 (1H,
dt, 3.9 and 13.1 Hz, H-2), 1.91 (1H, dd, 5.4 and 13.1 Hz, H-2),
3.32 (3H, s, OMe), 3.63 (1H, m, H-4′), 3.90 (1H, q, J ) 6.7 Hz,
H-5′), 3.99 (1H, m, H-3′), and 4.78 (1H, d, J ) 3.6 Hz, H-1′);
ESIMS m/z 185 (M + Na)+; HRESIMS m/z 185.0775 (M +
Na)+, calcd for C7H14O4Na 185.0790.
C
25H44O8Na 495.2934.
To a solution of 2-deoxyfucopyranoside 5 (0.5 mg) in pyridine
(100 µL) were added 4-(dimethylamino)pyridine (1 mg), tri-
ethylamine (1 µL), and benzoyl chloride (2 µL), and the mixture
was stirred at 37 °C for 8 h and then at 80 °C for 2 h. After
addition of saturated aqueous NH4Cl, the reaction mixture was
extracted with EtOAc. The organic layer was washed with
saturated NaHCO3, H2O, and brine. The organic phase was
evaporated, and the residue was separated on a silica gel
column (hexane/EtOAc, 95:5 and 90:10) to afford methyl 3,4-
bis-O-benzoyl-2-deoxy-R-L-fucopyranose (6; 0.055 mg): λext 237
9,13-Bis-(S)-MTP A E st er of t h e C-1-C-15 Segm en t
(14a ). To a solution of 10 (0.1 mg) in pyridine (50 µL) were
added DMAP (0.1 mg) and (R)-(-)-(MTPA)Cl (0.2 µL), and
stirring was continued at 37 °C for 9 h. N,N-Dimethyl-1,3-
propanediamine (1 µL) and saturated aqueous NaHCO3 were
added, and the reaction mixture was extracted with EtOAc.
The organic phase was washed with H2O and brine and dried
by a N2 stream. The residue was purified by preparative TLC
(hexane/EtOAc, 7:3) to afford a 9,13-bis-(S)-MTPA ester of 10
(0.1 mg) as a colorless oil. This MTPA ester was treated with
AcOH/MeOH/H2O (1:8:1; 50 µL) at 50 °C for 1 h. The solvent
1
(∆ꢀ -20.5) and 222 (+7.6) nm; H NMR (CD3OD) δ 1.26 (3H,
d, J ) 6.6 Hz, H3-6′), 2.14 (1H, ddd, J ) 12.4, 5.1, and 1.2 Hz,
1540 J . Org. Chem., Vol. 69, No. 5, 2004